SCHEMBL8047335

SCHEMBL8047335

CC(=O)Nc1ccc(/C=C/C(=O)NCC(=O)N(C)c2ccc(C)c(CBr)c2C)cn1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 18/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8047338 1.00 BDKRB2 (0.69) BDKRB2
SCHEMBL7977341 0.92 BDKRB2 (0.68) BDKRB2
SCHEMBL7977329 0.92 BDKRB2 (0.68) BDKRB2
SCHEMBL7978841 0.91 BDKRB2 (0.67) BDKRB2
SCHEMBL7978847 0.91 BDKRB2 (0.67) BDKRB2
SCHEMBL7965585 0.87 BDKRB2 (0.68) BDKRB2
SCHEMBL7965588 0.87 BDKRB2 (0.68) BDKRB2
SCHEMBL6641468 0.85 BDKRB2 (0.67) BDKRB2
SCHEMBL6641464 0.85 BDKRB2 (0.67) BDKRB2
SCHEMBL6640620 0.82 BDKRB2 (1.00) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed